Logo
x

Search

Subscribe Now

aNDA

Cipla Receives FDA's ANDA Approval for its HFA Inhalation Aerosol to Treat Acute Episodes of Bronchospasm or to Prevent Asthmatic Symptoms

Cipla Receives FDA's ANDA Approval for its HFA Inhalation Aerosol to Treat Acute Episodes of Bronchospasm or to Prevent Asthmatic...

  • April 10, 2020
Dr. Reddy's to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US

Dr. Reddy's to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US

  • April 15, 2019
PharmaShots Weekly Snapshots (October 28 – October 30, 2024)

    PharmaShots Weekly Snapshots (October 28 – October 30, 2024)

    • November 1, 2024
    Best Practices for External Data Reconciliation in Healthcare

      Best Practices for External Data Reconciliation in Healthcare

      • October 28, 2024
      PharmaShots Weekly Snapshots (October 21 – October 25, 2024)

        PharmaShots Weekly Snapshots (October 21 – October 25, 2024)

        • October 25, 2024
        PharmaShots Weekly Snapshots (October 14 – October 18, 2024)

          PharmaShots Weekly Snapshots (October 14 – October 18, 2024)

          • October 18, 2024
          Why Should You Shop For Kratom From A GMP-Approved Company This 2024?

            Why Should You Shop For Kratom From A GMP-Approved Company This 2024?

            • October 9, 2024
            AstraZeneca’s Fasenra Receives the CHMP’s Positive Opinion for Treating Eosinophilic Granulomatosis with Polyangiitis

              AstraZeneca’s Fasenra Receives the CHMP’s Positive Opinion for Treating Eosinophilic Granulomatosis with Polyangiitis

              • September 24, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.